Company
South AfricaPAREXEL Bloemfontein Early Phase Clinical Unit, Bloemfontein, South Africa – FDA Inspections
Inspection records and compliance data for PAREXEL Bloemfontein Early Phase Clinical Unit in Bloemfontein. 1 FDA inspection on record, last inspected March 30, 2017.
Company Profile
This profile covers PAREXEL Bloemfontein Early Phase Clinical Unit based in Bloemfontein, South Africa.
FDA Inspection History
- FDA inspections
- 1
- OAI
- 0
- VAI
- 0
- NAI
- 0
- Unclassified
- 1
- Form 483s
- 0
- Warning letters
- 0
Inspected March 30, 2017.
FDA inspections (1)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| March 30, 2017 | Not classified | Human Drugs | 1006011 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
PAREXEL Bloemfontein Early Phase Clinical Unit
FEI Number
3010924245
Address
6 Suid Street, Bloemfontein, South Africa
Country
South Africa
ID: fc06623b-32c0-45ca-98f8-b2e0ba92272b